Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis
Cardiovascular Research · 04.12.2024 · 120 (15) · 1851-1868
DOI: 10.1093/cvr/cvae174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 21.08.2024. Verfasst von Jannik H Larsen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark. Hauptthemen laut MEDLINE: Atherosclerosis, Myocytes, Smooth Muscle, Aorta, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Centre for Individualized Medicine in Arterial Diseases, Novo Nordisk Foundation, Independent Research Fund Denmark.
Abstract (Originalsprache)
Aims
Cellular communication network factor 2 (CCN2) is a matricellular protein implicated in fibrotic diseases, with ongoing clinical trials evaluating anti-CCN2-based therapies. By uncovering CCN2 as abundantly expressed in non-diseased artery tissue, this study aimed to investigate the hypothesis that CCN2 plays a pivotal role in maintaining smooth muscle cell (SMC) phenotype and protection against atherosclerosis. Methods and results Global- and SMC-specific Ccn2 knockout mouse models were employed to demonstrate that Ccn2 deficiency leads to SMC de-differentiation, medial thickening, and aorta elongation under normolipidaemic conditions. Inducing hyperlipidaemia in both models resulted in severe aorta malformation and a 17-fold increase in atherosclerosis formation. Lipid-rich lesions developed at sites of the vasculature typically protected from atherosclerosis development by laminar blood flow, covering 90% of aortas and extending to other vessels, including coronary arteries. Evaluation at earlier time points revealed medial lipid accumulation as a lesion-initiating event. Fluorescently labelled LDL injection followed by confocal microscopy showed increased LDL retention in the medial layer of Ccn2 knockout aortas, likely attributed to marked proteoglycan enrichment of the medial extracellular matrix. Analyses leveraging data from the Athero-Express study cohort indicated the relevance of CCN2 in established human lesions, as CCN2 correlated with SMC marker transcripts across 654 transcriptomically profiled carotid plaques. These findings were substantiated through in situ hybridization showing CCN2 expression predominantly in the fibrous cap.
Conclusion
This study identifies CCN2 as a major constituent of the normal artery wall, critical in regulating SMC differentiation and aorta integrity and possessing a protective role against atherosclerosis development. These findings underscore the need for further investigation into the potential effects of anti-CCN2-based therapies on the vasculature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark.
- Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, J. B. Winsløws Vej 4, DK-5000 Odense C, Denmark.
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
- Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.
- Department of Cell Biology, Complutense University School of Medicine, Madrid, Spain.
- Cellular and Molecular Biology in Renal and Vascular Pathology Laboratory, IIS-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Madrid, Spain.
ORCID-Profile: Andrietta Grentzmann, Gerard Pasterkamp, Michal Mokry, Lasse B Steffensen
Förderung
- Centre for Individualized Medicine in Arterial Diseases
- Novo Nordisk Foundation
- Independent Research Fund Denmark
- Simon Fougner Hartmanns Familiefond
- University of Southern Denmark
- Danish Diabetes Academy
Zitieren
APA
Larsen, J. H., Hegelund, J. S., Pedersen, M. K., Andersson, C. M., Lindegaard, C. A., Hansen, D. R., Stubbe, J., Lindholt, J. S., Hansen, C. S., Grentzmann, A., Bloksgaard, M., Jensen, B. L., Rodriguez-Díez, R. R., Ruiz-Ortega, M., Albinsson, S., Pasterkamp, G., Mokry, M., Leask, A., Goldschmeding, R., …, & Steffensen, L. B. (2024). Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis. Cardiovascular Research, 120(15), 1851-1868. https://doi.org/10.1093/cvr/cvae174
Vancouver
Larsen JH, Hegelund JS, Pedersen MK, Andersson CM, Lindegaard CA, Hansen DR, et al. Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis. Cardiovascular Research. 2024;120(15):1851-1868. doi:10.1093/cvr/cvae174
BibTeX
@article{Larsen2024,
author = {Larsen, Jannik H and Hegelund, Julie S and Pedersen, Matilde K and Andersson, Cecilie M and Lindegaard, Caroline A and Hansen, Didde R and Stubbe, Jane and Lindholt, Jes S and Hansen, Camilla S and Grentzmann, Andrietta and Bloksgaard, Maria and Jensen, Boye L and Rodriguez-Díez, Raúl R and Ruiz-Ortega, Marta and Albinsson, Sebastian and Pasterkamp, Gerard and Mokry, Michal and Leask, Andrew and Goldschmeding, Roel and Pilecki, Bartosz and Sorensen, Grith L and Pyke, Charles and Overgaard, Martin and Beck, Hans C and Ketelhuth, Daniel F J and Rasmussen, Lars M and Steffensen, Lasse B},
title = {Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {15},
pages = {1851--1868},
doi = {10.1093/cvr/cvae174}
}
EUVIMED